Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

108.00
Delayed Data
As of 4:00pm ET
 +1.91 / +1.80%
Today’s Change
94.55
Today|||52-Week Range
147.17
-6.70%
Year-to-Date
4 Stocks Move to Start the Week
5:02pm / GuruFocus News - Paid Partner Content
The Zacks Analyst Blog Highlights: Bank of America, Celgene, Goldman Sachs, L Brands ...
9:42am / Zacks.com - Paid Partner Content
Here's Why Bluebird Bio (BLUE) Stock Skyrocketed Today
12:41pm / Zacks.com - Paid Partner Content
Top Research Reports for Bank of America, Celgene & Goldman Sachs
Dec 08 / Zacks.com - Paid Partner Content
Bluebird Bio Becoming Household Name With This Promising Cancer Treatment
11:58am / TheStreet.com - Paid Partner Content
Why Thousands Will Attend ASH Hematology Conference in Atlanta This Weekend
Dec 08 / TheStreet.com - Paid Partner Content
Celgene Chart Bears Watching
11:33am / TheStreet.com - Paid Partner Content
Gilead Sciences to Acquire Cell Design Labs for $567 Million
Dec 08 / Zacks.com - Paid Partner Content
Key Feature in Marketks
11:30am / TheStreet.com - Paid Partner Content
Sanofi Begins Combo Studies on Multiple Myeloma Candidate
Dec 08 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close106.09
Today’s open110.07
Day’s range107.32 - 110.81
Volume8,215,319
Average volume (3 months)6,108,443
Market cap$83.5B
Dividend yield--
Data as of 4:00pm ET, 12/11/2017

Growth & Valuation

Earnings growth (last year)+28.35%
Earnings growth (this year)+23.52%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+22.70%
P/E ratio25.4
Price/Sales8.51
Price/Book12.52

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.14+0.40%
BMYBristol-Myers Squibb+0.60+0.96%
NVONovo Nordisk+0.29+0.56%
ABBVAbbVie+0.52+0.54%
Data as of 4:02pm ET, 12/11/2017

Financials

Next reporting dateJanuary 25, 2018
EPS forecast (this quarter)$1.92
Annual revenue (last year)$10.9B
Annual profit (last year)$2.0B
Net profit margin18.30%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President &
Chief Operating Officer
Scott Andrew Smith
Corporate headquarters
Summit, New Jersey

Forecasts